Vice President, Portfolio Chemistry
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Vice President, Portfolio Chemistry will report to the Senior Vice President, Medicinal Chemistry and Screening Sciences, and lead Revolution Medicines' multidisciplinary Portfolio Chemistry organization, with responsibility for Medicinal Chemistry and chemistry leadership across the discovery portfolio. This executive will provide strategic and scientific leadership for the advancement of oncology programs from validated hit series through development candidate nomination.
Working at the in
